References
- Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407–15.
- Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality of life research. PharmacoEconomics 2000;18:419–23.
- Man-Son-Hing M, Laupacis A, O’Connor A et al. Warfarin for atrial fibrillation; the patient’s perspective. Arch Intern Med 1996;156:1841–8.
- Quinn JV, Wells GA. An assessment of clinical wound evaluation scales. Acad Emerg med 1998;5:583–6.
- Wright JG. The minimal important difference: Who’s to say what is important? J Clin Epidemiol 1996;49:1221–2.
- Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol 2002;14:109–14.
- Sloan JA. Assessing the minimally clinically significant difference: scientific considerations, challenges and solutions. COPD 2005;2:57–62.
- Kirwan J. Minimal clinically important difference: the crock of gold at the end of the rainbow? J Rheumatol 2001;28: 439–44.
- Wells G, Beaton D, Shea B et al. Minimal clinically important differences: Review of methods. J Rheumatol 2001;28: 406–12.
- Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimally important difference in symptoms: A comparison of two techniques. J Clin Epidemiol 1996;49:1215–19.
- Redelmeier DA, Guyatt GH, Goldstein RS. On the debate over methods for estimating the clinically important difference. J Clin Epidemiol 1996;49:1223–4.